12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersVenus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday's pre-market session. The market value of their outstanding shares is at $8.7 million. Adlai Nortye (NASDAQ:ANL) sh

BenzingaJun 7 08:08 ET

Indaptus Therapeutics To Present New Positive Data On Decoy20 At Next-Gen Immuno-Oncology Conference

Indaptus Therapeutics, Inc, (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Offic

BenzingaJun 4 08:27 ET

Express News | Indaptus Therapeutics Announces New Positive Data From Ongoing Phase 1 Trial of Decoy20

ReutersJun 3 08:00 ET

Express News | Indaptus Therapeutics Presents New Cohort Data Confirming Original "Pulse-Prime" Hypothesis Via Phase 1 Clinical Trial Of Decoy20 At The ASCO Annual Meeting

BenzingaMay 29 08:27 ET

Maxim Group Maintains Indaptus Therapeutics(INDP.US) With Buy Rating, Maintains Target Price $8

Maxim Group analyst Jason McCarthy maintains $Indaptus Therapeutics(INDP.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 30.3

moomoo NewsMay 24 12:32 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cingulate Inc (CING), Indaptus Therapeutics (INDP) and Immunocore Holdings (IMCR)

TipRanksMay 24 12:11 ET